DEBIOPHARM

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow's standard of care to cure cancer & infectious diseases and improve patient quality of life. Our main activities include drug development, drug manufacturing and digital health investment... Together with his son Thierry Mauvernay, they were able to build a team of dedicated professionals with a broad range of expertise. Debiopharm is now a group of three companies active in drug development (Debiopharm International), drug manufacturing (Debiopharm Research & Manufacturing) and digital health investment (Debiopharm Innovation Fund). Debiopharm is the Life Science division of our parent company Après-demain SA, active in asset diversification and philanthropy.

Also known as: Debiopharm International, Debiopharm International SA, Debiopharm Research & Manufacturing SA

Primary location: Lausanne Switzerland